Elevance Health (NYSE: ELV) stock: the official figures
Elevance Health (Elevance Health, Inc.) is listed on the New York Stock Exchange under the ticker ELV and belongs to the health care sector. In fiscal 2025 it reported revenue of $199,125m and a net profit of $5,662m, according to the annual accounts it filed with the regulator.
Identifiers for Elevance Health: SEC CIK 1156039.
Fiscal 2025 figures
| Item | 2025 | 2024 | Change |
|---|---|---|---|
| Revenue | $199,125m | $177,011m | +12.5% |
| Operating profit | $7,199m | $7,862m | −8.4% |
| Net profit | $5,662m | $5,980m | −5.3% |
| Earnings per share | $25.28 | $25.81 | −2.1% |
| Operating margin | 3.6% | 4.4% | −0.8 pts |
| Net margin | 2.8% | 3.4% | −0.5 pts |
| Total assets | $121,494m | $116,889m | +3.9% |
| Equity | $43,882m | $41,315m | +6.2% |
| Cash | $9,491m | $8,288m | +14.5% |
| Operating cash flow | $4,290m | $5,808m | −26.1% |
Margins are calculated from the filed figures: operating profit and net profit over revenue.
10 fiscal years
| Fiscal year | Revenue | Operating profit | Net profit | Earnings per share | Document |
|---|---|---|---|---|---|
| 2025 | $199,125m | $7,199m | $5,662m | $25.28 | Annual report |
| 2024 | $177,011m | $7,862m | $5,980m | $25.81 | Annual report |
| 2023 | $171,340m | $8,499m | $5,987m | $25.38 | Annual report |
| 2022 | $156,595m | $8,283m | $5,894m | $25.10 | Annual report |
| 2021 | $138,639m | $7,559m | $6,158m | $25.04 | Annual report |
| 2020 | — | $6,360m | $4,572m | $18.23 | Annual report |
| 2019 | $104,213m | $5,999m | $4,807m | $18.81 | Annual report |
| 2018 | $92,105m | $5,426m | $3,750m | $14.53 | Annual report |
| 2017 | $90,040m | $4,175m | $3,843m | $14.70 | Annual report |
| 2016 | $84,863m | $4,801m | $2,470m | $9.39 | Annual report |
The full income statement, balance sheet and cash flow statement are in the annual accounts of Elevance Health. Year by year: revenue, net income and dividends paid. Purchases and sales by its executives and directors are in insider transactions.
Dividends
In fiscal 2025, Elevance Health paid $1,529m in dividends, 27.0% of its net profit, according to its cash flow statement.
| Fiscal year | Dividends paid | Share of net profit |
|---|---|---|
| 2025 | $1,529m | 27.0% |
| 2024 | $1,508m | 25.2% |
| 2023 | $1,395m | 23.3% |
| 2022 | $1,229m | 20.9% |
| 2021 | $1,104m | 17.9% |
| 2020 | $954.0m | 20.9% |
| 2019 | $818.0m | 17.0% |
| 2018 | $776.0m | 20.7% |
| 2017 | $705.0m | 18.3% |
| 2016 | $684.0m | 27.7% |
Cash paid out as dividends during the fiscal year, including dividends to minority shareholders of subsidiaries when the company does not report them separately. It is not the dividend per share.
Members of Congress who traded Elevance Health
In the congressional reports read up to 9 November 2026, 9 members have disclosed 18 transactions in Elevance Health: Gilbert Ray Cisneros, Jr. (3), Jared Moskowitz (3), Lisa C. McClain (3), Jefferson Shreve (2), Robert P. Bresnahan, Jr. (2), Val T. Hoyle (2) and 3 more.
Frequently asked questions about Elevance Health
- How much did Elevance Health earn in fiscal 2025?
- Elevance Health reported a net profit of $5,662m for fiscal 2025, on revenue of $199,125m. The year before it reported a net profit of $5,980m.
- Does Elevance Health pay a dividend?
- In fiscal 2025, Elevance Health paid $1,529m in dividends, 27.0% of its net profit, according to its cash flow statement.
- What are the earnings per share of Elevance Health?
- They were $25.28 in fiscal 2025, compared with $25.81 the year before.
- Where is Elevance Health listed?
- Elevance Health is listed on the New York Stock Exchange under the ticker ELV and belongs to the health care sector.
- Where do the figures for Elevance Health come from?
- From the annual report (Form 10-K) that Elevance Health files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
The annual accounts come from the annual report (Form 10-K) that Elevance Health files with the SEC, the US securities regulator. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.